elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Cyclophosphamide
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Cyclophosphamide
RIS
0.003
(Research Intensity Score)
Papers
431
Top papers
Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial
2022 · 239 citations
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
2019 · 743 citations
Ovarian damage from chemotherapy and current approaches to its protection
2019 · 665 citations
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group
2023 · 92 citations
Late-stage (radio)fluorination of alkyl phosphonates via electrophilic activation
2024 · 41 citations
Newest papers
Chemotherapy-induced myasthenia gravis presenting as isolated bulbar palsy in a patient with WHO type B3 thymoma
2026
Integrative genomic and proteomic analyses identify candidate genetic loci and genetically supported proteins in age-related macular degeneration
2026
Multidisciplinary management of pregnancy-associated breast cancer: a clinical pharmacy perspective on chemotherapy and perinatal outcomes
2026
Structural Characteristics and Immunoregulatory Effects of Colla Corii Asini Peptides with Iron‐Chelating Capacity
2026
Highlights from the 2025 ASH meeting: what’s new in lymphoma?
2026
A sample from the 100 top papers behind Cyclophosphamide.
Create a free account to browse them all →
Cyclophosphamide's history
Research intensity over time
Explore Cyclophosphamide's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Cyclophosphamide's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link